- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02235038
Metabolic Fuels Study
A Mechanistic Examination of Dietary Composition on Metabolic Fuels Availability
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The challenge in maintaining long-term weight loss is well known, however new research suggests diet quality may be the driving factor. A pilot study from our group demonstrated that a higher carbohydrate-containing diet was associated with lower total energy expenditure during weight loss maintenance (Ebbeling et al). These findings will be confirmed in the ongoing Framingham State Food Study (NCT02068885): Following weight loss on a standard diet, 150 overweight or obese adults (aged 18 to 65 years) will be randomized to one of three weight-loss maintenance diets varying in carbohydrate to fat ratios for 20 weeks.
However, the specific mechanisms underlying the calorie-independent effects of diet remain unclear. Another study from our group demonstrated lower energy availability (calculated based on caloric content of circulating metabolic fuel concentrations) in the fasting and late post-prandial periods in 8 overweight or obese young adults who were maintained on a low-fat (high-carbohydrate) diet (Walsh et al). We hypothesize that this lower metabolic fuel availability on a high carbohydrate diet results in part from increased anabolic changes within the adipocyte, favoring fat storage in preference to oxidation.
We will invite subjects already enrolled in the Framingham State Food Study to participate, aiming for a total of 30 subjects (with the goal of approximately equal numbers per diet group following randomization to assigned test diet in the parent study). Participants will be admitted to a research unit for a 24-hour period during weight maintenance on the test diet, during which they will undergo frequent blood sampling for the measurement of circulating metabolic fuels, hunger and satiety ratings, while consuming their assigned diet meals. Each participant will also undergo two abdominal subcutaneous fat aspiration biopsies under local anesthesia, the first immediately following weight loss (before initiating the test diet) and the second during weight maintenance, in order to perform gene expression analyses on the adipose tissue. Our main outcomes will be a comparison in energy availability (the sum of energy in the major metabolic fuels in the blood) between diet groups in the late postprandial period and changes in adipose tissue gene expression within-individuals and by diet group assignment. Other outcomes will include differences in hunger and satiety ratings, total 24-hour energy availability, and specific metabolic fuel concentrations.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02118
- Boston Medical Center
-
Boston, Massachusetts, United States, 02115
- Brigham & Women's Hospital
-
Boston, Massachusetts, United States, 02115
- Boston Children's Hospital
-
Framingham, Massachusetts, United States, 01702
- Framingham State University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
Inclusion Criteria (as detailed in Framingham State Food Study, NCT02068885)
- Aged 18 to 65 years
- BMI ≥ 25 kg/m2
- BMI < 40 kg/m2 and weight ≤ 300 lbs (136 kg)
- Medical clearance from a primary care provider
- Student or employee at Framingham State University throughout enrollment in the study
- Willing and able to eat and drink only the foods and beverages on the study menus
- Willing to eat in the dining hall
- Willing to abstain from consuming alcohol during participation
Additional Inclusion Criteria:
• Willing to undergo additional procedures in this ancillary study
Exclusion Criteria:
Exclusion Criteria (as detailed in Framingham State Food Study, NCT02068885)
- Change in body weight exceeding ±10% during prior year
- Recent adherence to a special diet
- Recent adherence to a vigorous physical activity regimen (e.g., participation in a varsity sport)
- Chronic use of any medication or dietary supplement that could affect study outcomes
- Current smoking (1 cigarette in the last week)
- Heavy baseline alcohol consumption or history of binge drinking
- Physician diagnosis of a major medical/psychiatric illness or eating disorder
- Abnormal blood glucose, TSH, CBC, BUN, Creatinine
- ALT greater than 150% of the normal upper limit
- Plans for a vacation during the study that would preclude adherence to prescribed diet
- Additional exclusions for female participants: Irregular menstrual cycles; any change in birth control medication during the 3 months prior to enrollment; pregnancy or lactation during the 12 months prior to enrollment
Additional Exclusion Criteria:
- Allergy or prior reaction to Lidocaine
- Medical condition or medication that would increase risk of bleeding, infection or skin reactions
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Active Comparator: Low carbohydrate diet
|
Composition (by proportion of calories) : 15% carbohydrate, 65% fat, 20% protein
Other Names:
|
|
Active Comparator: Moderate carbohydrate diet
|
Feeding study.
Composition (by proportion of calories): 40% carbohydrate, 40% fat, 20% protein
|
|
Active Comparator: High carbohydrate diet
|
Feeding study.
Composition (by proportion of calories): 60% carbohydrate, 20% fat, 20% protein
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Late postprandial energy availability
Time Frame: 10 - 15 weeks after initiation of test diets
|
Post-prandial energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission.
Time of interest includes 2.5 - 5 hr in the postprandial period after breakfast, lunch and dinner.
|
10 - 15 weeks after initiation of test diets
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Late postprandial energy availability, with lactate excluded
Time Frame: 10 - 15 weeks after initiation of test diets
|
Post-prandial energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, and ketoacids), as measured during a 24 hr inpatient admission.
Time of interest includes 2.5 - 5 hr in the postprandial period after breakfast, lunch and dinner.
(Lactate is metabolized primarily by the liver, which uses this substrate to produce glucose.
Thus, including lactate in the calculation of metabolic fuels may comprise "double counting" -- and not accurately reflect actual fuel availability to body tissues)
|
10 - 15 weeks after initiation of test diets
|
|
Fasting energy availability
Time Frame: 10 - 15 weeks after initiation of test diet
|
Fasting energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission.
|
10 - 15 weeks after initiation of test diet
|
|
Total energy availability
Time Frame: 10 - 15 weeks after initiation of test diets
|
Total energy availability calculated as the sum, in kcal/L, of energy from circulating metabolic fuels (glucose, non-esterified fatty acids, lactate and ketoacids), as measured during a 24 hr inpatient admission.
|
10 - 15 weeks after initiation of test diets
|
|
Hunger
Time Frame: 10 - 15 weeks after initiation of test diets
|
Measured during a 24 hr inpatient admission.
|
10 - 15 weeks after initiation of test diets
|
|
Satiety
Time Frame: 10 - 15 weeks after initiation of test diets
|
Measured during a 24 hr inpatient admission.
|
10 - 15 weeks after initiation of test diets
|
|
Glucose
Time Frame: 10 - 15 weeks after initiation of test diets
|
Concentration during 24-hr inpatient admission
|
10 - 15 weeks after initiation of test diets
|
|
Non-esterified fatty acids
Time Frame: 10 - 15 weeks after initiation after test diet
|
Concentration during 24-hr inpatient admission
|
10 - 15 weeks after initiation after test diet
|
|
Lactate
Time Frame: 10 - 15 weeks after initiation of test diets
|
Concentration during 24-hr inpatient admission
|
10 - 15 weeks after initiation of test diets
|
|
Ketoacids
Time Frame: 10 - 15 weeks after initiation of test diets
|
Concentration during 24-hr inpatient admission
|
10 - 15 weeks after initiation of test diets
|
|
Insulin
Time Frame: 10 - 15 weeks after initiation of test diets
|
Concentration during 24-hr inpatient admission
|
10 - 15 weeks after initiation of test diets
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effect modification by insulin secretion
Time Frame: 10 - 15 weeks after initiation of test diets
|
We will test for an interaction by insulin secretion (as measured by plasma insulin 30 minutes into a standard oral glucose tolerance test) of the relationship between diet and metabolic fuels concentration.
|
10 - 15 weeks after initiation of test diets
|
|
Adipocyte studies of anabolic status
Time Frame: 10 - 15 weeks after initiation of test diets
|
Adipose tissue gene expression studies (assessed by mRNA levels of selected candidate genes involved in lipid storage, fatty acid and lipid biosynthesis, angiogenesis, inflammation).
Change from baseline.
|
10 - 15 weeks after initiation of test diets
|
|
Adipose tissue histology
Time Frame: 10 - 15 weeks after initiation of test diets
|
Change from baseline.
|
10 - 15 weeks after initiation of test diets
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Kim Shams, MD, Boston Children's Hospital
Publications and helpful links
General Publications
- Ebbeling CB, Swain JF, Feldman HA, Wong WW, Hachey DL, Garcia-Lago E, Ludwig DS. Effects of dietary composition on energy expenditure during weight-loss maintenance. JAMA. 2012 Jun 27;307(24):2627-34. doi: 10.1001/jama.2012.6607.
- Walsh CO, Ebbeling CB, Swain JF, Markowitz RL, Feldman HA, Ludwig DS. Effects of diet composition on postprandial energy availability during weight loss maintenance. PLoS One. 2013;8(3):e58172. doi: 10.1371/journal.pone.0058172. Epub 2013 Mar 6.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- IRB-P00014678
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
Clinical Trials on Moderate carbohydrate diet
-
Brigham and Women's HospitalBoston Children's Hospital; Boston Medical Center; Nutrition Science Initiative; New Balance Foundation and other collaboratorsCompleted
-
Yang TaoRecruitingType 1 Diabetes | Diet Intervention | Glucose ControlChina
-
Vastra Gotaland RegionCompleted
-
University of WashingtonNational Heart, Lung, and Blood Institute (NHLBI)CompletedDyslipidemias | Metabolic Syndrome XUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedType 2 DiabetesUnited States
-
Universitaire Ziekenhuizen KU LeuvenRecruitingDiabetes Mellitus, Type 1Belgium
-
Edgar National Centre for Diabetes ResearchCompletedInsulin ResistanceNew Zealand
-
University of North Carolina, Chapel HillNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedDiabetes Mellitus, Type 1 | Overweight and ObesityUnited States
-
Montreal Heart InstituteCompleted
-
Kaiser PermanenteNational Center for Complementary and Integrative Health (NCCIH)CompletedHypertension | ObesityUnited States